If it is higher than the economic loss resulting from NNV infection, the vaccine is not of practical use. Saccharomyces cerevisiae (S. crevisiae) has great potential for large scale culture and is classified as Generally Recognized as Safe (GRAS) (Nevoigt, 2008).